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Abstract
Background: Hypertension (HTN) is a common, costly, and deadly disease that is often under
recognized, under diagnosed, and undertreated in the primary care setting. Despite the presence
of effective treatment strategies, uncontrolled HTN remains a persistent problem.
Purpose: The aim of this Doctor of Nursing Practice (DNP) project was to improve the quality
of HTN care delivered to adults in a primary care practice. Goals were targeted to decrease
providers’ clinical inertia by improving their ability to make better diagnosis and treatment
decisions after reviewing more comprehensive objective data.
Methods: Using the Chronic Care Model in an independent primary care setting in New
Hampshire an ambulatory blood pressure monitoring (ABPM), home blood pressure monitoring
(HBPM), clinical practice guidelines, and patient and provider education were used to improve
the detection and management of hypertension. Patients were followed over two to three visits
including an initial visit for ABPM set-up and up to two subsequent HTN follow-up visits.
Results/Interpretations: One hundred percent of patients who underwent successful ABPM had
their HTN status assessed and those with uncontrolled HTN had changes made to their
medications to improve control. The percentage of patients with uncontrolled HTN decreased by
more than half at visit two (44.7%) compared with visit three (20%), which was statistically
significantly different, t (58) = 2.25, p = 0.028, 95% CI [0.027, 0.466].
Implications: QI projects addressing provider, system, and patient barriers may be effective at
overcoming the barrier of providers’ clinical inertia and improving some patients’ selfmanagement of their disease resulting in improved HTN control.
Keywords: ambulatory blood pressure monitoring, chronic care model, clinical inertia, home blood
pressure monitoring, hypertension, practice guideline, primary care, self-efficacy
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Introduction and Background
Hypertension (HTN) is the most commonly treated disease in primary care
(Huebschmann, Mizrahi, Soenksen, Beaty, & Denberg, 2012); yet it is one of the most deadly,
costly, and poorly managed diseases in the United States (Centers for Disease Control and
Prevention [CDC], 2012). According to the CDC (2012), the estimated prevalence of HTN is
one in every three adult Americans, with less than half of those diagnosed having attained
satisfactory control of their disease. The health care costs associated with HTN totals $131
billion per year (CDC, 2012). Uncontrolled HTN is associated with significant morbidity and
mortality including increased risk of stroke, myocardial infarction, chronic kidney disease, heart
failure, and death (CDC, 2012). Worldwide, HTN contributes to over nine million deaths per
year (James, Dolan, & O'Brien, 2014).
Controlling blood pressure (BP) is crucial in the prevention of cardiovascular disease,
especially since, after years of decline, the death rates for coronary heart disease and stroke
leveled off and have begun to rise again. Despite the fact that HTN is controllable, in essence,
nearly “curable”, control rates vary, with the majority of individuals with HTN remaining
uncontrolled or under controlled (DeMartinis, 2009; DeMartinis, Kent, & Uphold, 2013).
Lifestyle modifications and pharmacotherapy treatments can successfully control HTN in
more than nine out of ten patients (Yaxley & Thambar, 2015). There are many classes of
inexpensive and well-tolerated medications for the treatment of HTN that have been proven to be
effective and safe through rigorous clinical trials and over time (Margolis et al., 2012).
Modifications such as weight maintenance, a healthy diet, and regular exercise can have a
significant impact on HTN (Masuo, 2015). It is estimated that following the Dietary Approaches
to Stop Hypertension (DASH) diet has the potential to decrease systolic blood pressure an
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average of 8 to 14 mm Hg (Chobanian et al., 2003). A 10 mm Hg decrease in systolic BP can
reduce a patient’s risk of dying from a stroke by 40% and from heart disease by 30% (Carter,
Bosworth, & Green, 2012).
Improving the quality of HTN care provided is critical to addressing this issue. Most
patients with HTN have their HTN managed by their primary care provider (PCP). In the United
States, four out of five HTN office visits for patients who have HTN are performed by PCPs, not
by specialists (Margolis et al., 2012). Moreover, HTN is the most commonly billed primary
care visit type (Egan, Zhao, & Axon, 2010). It is evident the primary care setting is where the
quality of HTN care needs to improve.
It is universally agreed that the prevention and management of HTN are essential for
good health. For the last three decades, the United States Department of Health and Human
Services (DHHS) (2016) has included improving the prevention, detection, and management of
hypertension as part of their national goals for improving the health of all Americans. Healthy
People 2000, Healthy People 2010, and Healthy People 2020 objectives have included outcomes
aimed at increasing antihypertensive medication adherence; decreasing the prevalence of HTN;
increasing the proportion of patients following the recommended lifestyle modification
guidelines; increasing the percentage of patient who have their BP checked and can recognize the
result as normal or HTN; and increasing the proportion of patients with controlled HTN (DHHS,
2016). As we pass the midway point of the 2020 objectives, it appears that HTN control is
modestly improving, but there is still much room for progress (DHHS, 2014). More Americans
are being diagnosed with HTN each year, yet only 44% of the diagnosed population has achieved
satisfactory control of their hypertension (DHHS, 2014). Provider, system, and patient issues all
contribute to the under management of this treatable condition.
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Many practice gaps are present in healthcare preventing patients from being diagnosed
and treated effectively for HTN. A diagnosis of HTN should be considered in any patient with a
systolic BP greater than 140 mm Hg or a diastolic BP greater than 90 mm Hg on two separate
occasions (James et al., 2014). Despite robust guidelines for the diagnosis and treatment of
HTN, many providers fail to recognize repeated abnormal BP measurements (Bosworth et al.,
2009).
Even when providers do recognize uncontrolled HTN, they do not always address it
during the patient visit (Bosworth et al., 2009; Sutton, Wilson, Kaboli, & Carter, 2010). In a
retrospective analysis of patients with uncontrolled HTN, researchers discovered nearly threequarters of patients with uncontrolled HTN had at least two health care visits within the last year
for various health issues, in which their HTN was not addressed (Frieden, King, & Wright,
2014). Experts agree the main provider-related contributor to the issue of uncontrolled HTN is
clinical inertia, as evidenced by the extensive failure of providers to start, intensify, or adjust
HTN treatment when management goals are unmet (Huebschmann et al., 2012).
Factors reported by providers that contribute to this phenomenon of clinical inertia
include knowledge deficits, fear of medication side effects, difficulty keeping up with treatment
recommendations, and lack of time and resources (Khatib et al., 2014). Providers also question
the reliability of the BP readings upon which they base their treatment decisions (Lebeau et al.,
2014). At times, providers see a high BP reading and ignore it in disbelief, attributing the
elevated reading to pain or stress, not uncontrolled HTN. On occasion, providers recognize that
patients are not below their treatment goal but will not act because they are close to their
treatment goal (Lebeau et al., 2014). More often, many providers do not order the appropriate
antihypertensive medications despite substantial evidence supporting specific drug classes as
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first-line therapy (Markidakis & DiNicolantonio, 2014). The phenomenon of clinical inertia
does not only include diagnostic and pharmacologic inaction; it also involves the failure of
providers to include important lifestyle modification education to support patients’ selfmanagement of their disease (Lebeau et al., 2014).
Another potential barrier in controlling HTN is the reliability of BP readings on which
providers must base diagnosis and treatment decisions. Hypertension is a “silent killer”; many
patients have no signs or symptoms of their disease, until the chronically increased BP affects
other organ systems and end organ damage reveals the HTN diagnosis. This makes the need for
accurate BP measurements essential for providers to make effective diagnosis and treatment
decisions. One of the main contributors to the actual and perceived inaccuracy of in-office BP
readings in predicting the presence of HTN is the “white coat” effect. For approximately one out
of three patients, the anxiety and/or stress of going to a provider causes a temporary increase in
blood pressure that is not observed outside the clinical environment (Cobos, Haskard-Zolnierek,
& Howard, 2015). In addition to the white coat effect, in-office BP measurements are also
subject to errors in technique.
Myers, Kaczorowski, Dawes, and Godwin (2014) performed a review of the literature on
the accuracy of various blood pressure monitoring techniques used in primary care offices. They
concluded that routine manual office BP (MOBP) monitoring is subject to many factors that limit
the reliability of readings including selecting the incorrect cuff size, deflating the cuff too
rapidly, taking a reading too soon after activity, and individual office staff idiosyncrasies.
Manual BP readings in routine clinical practice are 9 mm Hg systolic and 6 mm Hg diastolic
higher than readings measured in a controlled research setting. Studies using automated office
BP (AOBP) have shown that it is more accurate than MOBP, and it decreases the ‘white-coat’
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effect. However, it is still subject to many of the same limiting factors as MOBP. The main
limitation of both manual and automated office BP monitoring, is that it is just one reading, at
one point in time. Factors such as pain, illness, and the white coat effect make in office BP
readings unreliable.
There are also many patient-related factors contributing to the high number of Americans
walking around with undiagnosed or uncontrolled hypertension. Non-adherence to
antihypertensive medications is suggested as a leading cause of uncontrolled HTN in the U.S.
(Dave et al., 2013). Many patients do not adhere to their HTN medications and do not adhere to
recommended lifestyle modifications aimed at lowering their BP (Hacihasanoglu & Gözüm,
2011). For example, patient-related factors include: suboptimal medication adherence related to
cost, fear of side effects, mistrust of providers, denial of diagnosis, pill burden, and patients’
beliefs (Polinski et al., 2014). Patient capability is also an issue (Khatib et al., 2014). Many
patients do not have the baseline knowledge about HTN and lifestyle risk factors to make healthy
choices (Khatib et al., 2014). Additionally, many patients lack the motivation, resources, and
supports needed to make meaningful lifestyle modifications directed at improving BP (Khatib et
al., 2014). The asymptomatic nature of HTN also contributes to patients’ perceived lack of need
for personal transformation (Mafutha & Wright, 2013).
Patients’ non-compliance and providers continued ignorance to prescribe and manage
HTN through multifaceted holistic treatment protocols are the two major factors contributing to
the persistent lack of effective BP management in the US population (DeMartinis, 2009;
DeMartinis, et al., 2013). DeMartinis argues that providers must appreciate the need for
refinement in their exiting diagnosis and treatment protocols, based on current practice
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guidelines and quantifiable BP data readily available through non-invasive assessment devices
that measure hemodynamic and BP parameters over time.
Theoretical Framework
The purpose of this DNP project was to design and implement a quality improvement
(QI) project to address some of the provider, system, and patient issues that contribute to
suboptimal hypertension detection and management. Hypertension is a chronic condition and
patients require a coordinated approach to adequately manage this lifelong disease.
The Chronic Care Model (CCM) was an appropriate model to choose for the design and
implementation of this project as it integrates all aspects of the healthcare system. The CCM
(see schema in Appendix A) is a theoretical model that was designed to outline a process for
improving the management of chronic illnesses within healthcare systems (Wagner, Davis,
Schaefer, Von Korff, & Austin, 1999; Wagner et al., 2001). The model has six components.
The first four elements center around the practice environment- the organizational design of the
healthcare system, clinical information systems, delivery system design, and the use of decision
supports. The last two components are patient-centered and include self-management support
and utilization of community resources. The complex nature of chronic illnesses require a
multifaceted approach. This model is ideal as it breaks down complex care into a multi-factorial
approach that allows for analysis of the various systems and person-environment transactions
within a particular healthcare system.
Using this framework, a review of the current HTN detection and management workflow
at the large practice with two office sites was examined by the DNP student, the practice owner,
and the offices’ practitioners. Strong points and weak points in each of the domains were
identified. Weak areas were targeted as areas to introduce change. Under the domain of
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organizational design of the system, identified strengths included involved leadership, an
environment that encourages QI efforts, and incentives to improve the quality of chronic care
including third-party insurance payments. The main weakness identified was a lack of a chronic
care current strategy. In the domain of delivery system design, identified areas of strength
included flexible practice hours outside of regular working hours, monthly staff meetings to
improve the delivery of care, and the practice’s high value on continuity of care. An area of
improvement identified was to develop a plan of care for patients with HTN, including regular
care, targeted interventions, and self-management support.
Under clinical information systems, the electronic medical record (EMR), which allows
reporting and trending of patient information were identified as a strength. Using the EMR in
new ways to help communicate the course of hypertension care was identified as an area for
improvement. Improving the accuracy of BP measurement was also targeted for improvement in
this model domain. In looking at decision support systems it was determined that practitioners
independently make use of many decisions supports, such as clinical guidelines, but the practice
does not provide them. Identifying evidenced-based guidelines for HTN and supporting them
with provider education were identified as two areas of potential improvement. Current
strengths identified in the area of patient self-management support included close follow-up of
chronic conditions. Areas for improvement that were targeted included increasing patient
support and education. Under the domain of utilization of community resources, practice
strengths included the practice’s many partnerships with various community organizations. An
identified weakness was a lack of follow up to make sure patients are utilizing these resources.
Through the application of the CCM, specific areas of improvement targeting the
providers, system, and patients were identified. The model helped identify resources to address
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the practice’s gaps in the management of their hypertensive patients. A review of the literature
based on the appraisal of the strengths and weaknesses of the primary care setting was executed
to identify resources that could be used to target these areas of chronic HTN care in need of
improvement. Specific search criteria were identified during the process of the healthcare
system appraisal.
Review of the Literature
Clinical practice guidelines (CPGs) are one source of evidence-based recommendations
outlining how to improve the quality of care delivered, including HTN management. According
to the Institute of Medicine (IOM) (2011), CPGs are evidence-based recommendations intended
to improve the quality of patient care. They are informed by systematic reviews and include an
assessment of the risks and benefits of treatment options. Healthcare experts believe that CPGs
have the potential to decrease inconsistencies in care and improve healthcare outcomes
(Etxeberria et al., 2013). Several HTN guidelines are widely accepted and used in primary care
settings.
In 2014, the Eighth Joint National Committee (JNC-8) published its latest version of
evidence-based guidelines for the management of hypertension in adults (James et al., 2014).
The JNC-8 guidelines are considered a much-anticipated improvement over the previously
widely accepted JNC-7 guidelines. Experts agree following its recommendations can help
improve the quality of HTN care, although experts are still debating a few details of the
recommendations for the treatment of HTN in elders (Kovell et al., 2015). The guideline was
developed after a systematic review of the literature and the collaboration of hypertension
experts, to ascertain which of the broad range of antihypertensive drugs should be implemented,
at what BP threshold, and with what goals in mind (Hernandez-Vila, 2015). The guideline is
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based on the highest levels of evidence to date from randomized, controlled clinical trials
(Hernandez-Vila, 2015). Each recommendation is discussed at length and accompanied by a
grade based on its level of evidence.
Experts agree that almost all patients with HTN can benefit from pharmacotherapy
(Markidakis & DiNicolantonio, 2014). The JNC-8 guideline provides medication therapy
recommendations based on the patient’s race, age, and other comorbid factors. The guideline
also provides specific BP goals for HTN treatment. Moreover, the guideline provides specific
recommendations about how to adjust or escalate therapy.
In addition to consideration of effective pharmacotherapies, the management of
hypertension should also include patient education about lifestyle modifications intended to
improve BP (Chobanian, 2003). The AHA/ACC Guideline on Lifestyle Management to Reduce
Cardiovascular Risk: A Report of the American College of Cardiology/American Heart
Association Task Force on Practice Guidelines is another CPG that is potentially helpful in
informing and improving the quality of HTN management in the primary care setting (Eckel et
al., 2014). This guideline provides evidenced-based recommendations on lifestyle modifications
patients can make to improve their BP as part of overall heart health. Each recommendation is
graded based on the strength of the evidence supporting it. Like the JNC-8 guidelines, these
guidelines are devised by leading experts and are designed to support clinical decision-making
yeast, are not a substitute for providers own clinical judgment (Eckel et al., 2014; James et al.,
2014). Both these guidelines meet the IOM (2011) standards to be considered trustworthy, highquality CPGs.
A review of the recent literature was performed to explore how different blood pressure
measurements techniques are being used in the treatment of HTN in the primary care setting.
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Home or ambulatory blood pressure measurement (ABPM) has been studied extensively over the
past twenty years (Andalib et al., 2012; Myers et al., 2014). Numerous studies have shown the
ABPM can help to predict an individual’s likelihood of future cardiovascular diseases (Stergiou,
Siontis, & Ioannidis, 2010; Verdecchia, Angeli, & Cavallini, 2007). According to Boggia et al.
(2014), part of the problem for providers in using BP measurements to guide treatment decisions
is the natural variations in BP- (e.g.- circadian, day-to-day, reading-to-reading, visit-to-visit).
Ambulatory BP monitoring helps cut through the confusion by offering a greater number of
readings over time that are free from the white coat effect (Boggia et al., 2014). Ambulatory BP
monitoring is widely accepted as a more accurate and diagnostic method of monitoring BP over
time than office methods (Andalib et al., 2012; Boggia et al., 2014; Myers et al., 2014). The
European Society for Hypertension (Mancia et al., 2013) and the National Institute for Health
and Clinical Excellence (McManus, Caulfield, Williams, & National Institute for Health and
Clinical Excellence, 2012), the U.S. Preventative Services Task Force (2015) all recommend
ABPM as the preferred method for diagnosing and managing HTN.
Project Design, Methods, and Implementation
A quality improvement (QI) project design using provider education, clinical practice
guidelines, two types of home-based blood pressure monitoring, and evidence-based patient
education to improve the quality of standard HTN management delivered in one primary care
practice was used. Quantitative and qualitative methods data were collected from BP monitors,
patient and provider questionnaires, and communications with providers and patients. The
activities included educational sessions at staff meetings, as well as one-on-one provider and
staff education. Patient-centered interventions including BP monitoring and patient education
were provided over the course of several office visits.
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Setting and Resources
The project took place in the offices of a privately-owned primary care practice in New
Hampshire. The practice employs three nurse practitioners, one licensed practical nurse and four
medical assistants as well as three secretaries and several office managers. The providers and
staff work on assignment across two office sites and patients may be seen at either office for an
appointment. The two offices of the practice have a combined patient panel of approximately
4,000 patients from birth to ninety years of age and older. Nearly half of the patients have
private insurance, and the other half have Medicare. About 1% of patients have no insurance or
Medicaid. The exact number of patients and the demographics of the desired population of adult
patients diagnosed hypertension were undefined.
Both practice locations reside in a rural county as do the majority of the practice patients.
This county is comprised of 14 towns and one city (The State of New Hampshire, n.d.).
According to the United States Census Bureau (2015), the county had a 2013 population of
42,984 residents. 96.9% of the residents are White alone, 1.5% are two or more races, 1.4% are
Hispanic or Latin, 0.6% are Black or African American, 06.% are Asian, and 0.3% are American
Indian or Alaska Native. 18.3% of the population are elderly (65 years and older), and 19.9%
are under the age of 18 years. The 2009-2013 median household income is below the state
average of $64,916 at $54,463 and slight above the U.S. median household income of $53,046.
In 2011-2013, 9.9% of the County residents lived below the poverty line. The state average is
8.7%, and the U.S. average is 15.4% for the same timeframe.
Two types of monitors were used during the project. The first type of monitor used was
the Welch Allyn’s ABPM 7100© monitor and its companion CarioPerfect Workstation©
software. This monitor was designed to be worn for at least 24 hours and as long as several
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days. It takes BP measurements automatically at specific intervals over the 24-hour period and
stores all of the information for easy retrieval. The software that goes with the monitor generates
a report on BP trends over time that the provider can review. The second type of monitors were
the typical home blood pressure monitors (HBPM), which are inexpensive monitors that can be
purchased at any drug store or large retailer. This type of monitor takes a blood pressure
measurement and shows a reading when a button is pushed. These monitors are not designed to
be worn throughout the day. They are used primarily by patients to track their own BP
measurements at home as directed by their PCP.
Description of the Project Population
The target patient population for this QI project was all adult patients aged 19 to 74 years
who had suspected HTN, prehypertension, or an established diagnosis of HTN. The sample
contained both newly diagnosed HTN patients and patients with existing HTN. The initial goal
was to recruit 50 patients and forty-eight patients were ultimately recruited into the QI project.
Patients were already current practice patients, English-speaking, literate, and had either private
or public health insurance. All patients were physically able to measure their BP at home. They
also had an upper arm circumference that was matched with an appropriately sized ABPM cuff.
Exclusion criteria for patient participation in the QI project included pregnancy, hypertension
that was already managed by a specialist, cognitive impairment, presence of a non-sinus heart
arrhythmia, and the presence of an implanted defibrillator or pacemaker. Patients who had any
medical contraindication to repeated BP measurement in their non-dominant upper arm,
including, but not limited to a history of mastectomy, poor circulation, the presence of a wound,
or arteriovenous shunt, were excluded.
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Ethics and Human Subjects Protection
Since the DNP project was a QI initiative, it was determined that submitting for and
obtaining Institutional Review Board approval was not required. All participants were protected
by the Health Insurance Portability and Accountability Act of 1996 (HIPAA) which, among
other guarantees, protects the privacy of patients’ health information (Modifications to the
HIPAA Privacy, Security, Enforcement, and Breach Notification Rules, 2013). Additionally, the
DNP student and practice personnel who carefully conducted this project followed the Standards
of Care for practice in a primary care office. All information collected as part of evaluating the
impact of this project was aggregated data from the project participants and did not include any
potential patient identifiers. The risk to patients participating in this project was no different
from the risks of patients receiving standard HTN care. Participant confidentiality was assured
by coding the participants using individual identification numbers. The list of participants and
their identifying numbers were kept in locked filing cabinets each practice office, only accessible
to the project coordinators. All electronic files containing identifiable information were
password protected to prevent access by unauthorized users and only the project coordinators
had access to the passwords.
Project Actualization
Over a four-month period, patients with suspected or diagnosed HTN were followed over
several visits. During the first visit, patients were fitted with an ABPM for 24-hours to gain a
reliable assessment of their HTN status. During the second visit, patients received their ABPM
results, any necessary testing, medication changes as appropriate, and education about HBPM
and recommended lifestyle modifications (LM) as deemed appropriate by their primary care
provider. Patients who were determined to have white coat hypertension (WCH) via ABPM,
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without a co-diagnosis of prehypertension, did not receive HBPM instructions and LM education
and were not followed on their next visit. All other patients were seen for a third hypertension
follow-up visit to review HBPM results, reassess hypertension control, and reinforce LM
education.
The first phase of this project was pre-project implementation, which consisted of staff
training, patient recruitment, gathering equipment, and figuring out the logistics of the project.
The DNP student first introduced the project to providers and staff at the practice’s monthly staff
meeting. Practice staff were educated about the planned interventions, the goals of project, their
role in the project, and what to expect. Staff education included teaching ancillary staff about
methods to obtain accurate measurements of office BP. The correct procedure included waiting
until the patient had been seated for at least 5 minutes in a chair with their back supported and
their feet flat on the floor. Staff members were instructed to take a reading in both arms using
office AOBP unless contraindicated, and record these readings in the electronic medical record
(EMR).
The DNP student investigated ABPM, presented the practice owners with option, and the
practice owner purchased two ABPMs. The DNP student also examined reimbursement and
billing for monitoring HTN using ABPMs from various insurance companies. Using the Process
Theory (Issel, 2014) the student calculated the project’s cost and created a budget based on
potential reimbursement. The practice owner purchased two Welch Allyn 7100 ©ABPMs and
the CarioPerfect Workstation © software to run the monitors as an in-kind contribution to the
project. The DNP student and the practice’s staff member in charge of the practice’s EMR,
computers, and network system installed all the ABPM software. Prior to implementation, the
DNP student became familiar with using the Welch Allyn 7100 ABPM© and its software. Prior
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to implementation, a staff volunteer wore the monitor for 24-hours and the data was downloaded
using the CarioPerfect Workstation © to ensure functionality and accuracy of the system.

This

was also done to elicit the tolerability of the monitoring process before placing the device on any
patients.
In preparation for the project, the DNP student also met with the providers as a group and
again with each provider one-on-one. The DNP student provided copies of the JNC-8 guidelines
and AHA/ACC guidelines and reviewed them with each practitioner. Providers were also
educated about the diagnosis requirements for white coat hypertension (WCH), masked HTN,
controlled HTN, uncontrolled HTN, resistant hypertension, and how to distinguish patients’
nocturnal dipper status and its clinical significance. The student reviewed the functioning of the
ABPM and how to run and interpret the reports. The student also educated the providers about
ICD-10 and CPT codes for billing. Provider feedback was solicited and incorporated into the
project design. The practice owners and the DNP student’s chairperson and mentor signed off on
the proposed project prior to implementation.
Patient recruitment was done by the DNP student and practice providers based on the
project’s inclusion and exclusion criteria. Providers identified patients with questionable BP
control including patients with suspected undiagnosed hypertension, suspected WCH, patient
whose HTN control was questionable based on variable in-office and/or home readings, patients
with elevated BP readings suggestive of uncontrolled HTN on antihypertensives, and patients
who were resistant to starting an antihypertensive for previously diagnosed HTN. After speaking
with the patient about the need for ABPM to clarify their hypertensive status, the provider
created a telephone encounter for the DNP student in the EMR, which was electronically linked
to the patient’s record.
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Next, the DNP student called identified patients to schedule them to be set up with
ABPM. During the phone call, the DNP student explained the purpose of the monitor, why their
provider had recommended it for them, and what to expect. The DNP student also reviewed the
list of inclusion and exclusion criteria to ensure each patient was eligible. Patients were
instructed to schedule at a time when wearing the ABPM will not cause unnecessary
inconvenience. Patients were advised that they could not shower with the monitor on or get it
wet, they should not use power tools while wearing the monitor, and that driving should be kept
to a minimum while they were wearing the monitor. Patients were also advised that they should
come to their appointment wearing loose clothing under which the monitor could fit. Interested
patients were scheduled for an office visit with their provider during a time when the DNP
student was expected to be present. Recruitment of patients was planned to cease after 50
patients had undergone ABPM or at the end of the four-month project implementation
timeframe, whichever came first.
The selected patients’ first visit for ABPM ‘set-up’ included a standard HTN follow-up
visit including a history and physical exam as deemed appropriate by each patient’s provider.
During the scheduled visit, the healthcare providers and the DNP student reviewed the inclusion
and exclusion criteria and signed off on a document created to ensure the participants met
selection criteria for participation in the QI project (see Appendix B for patient eligibility
checklist). For each patient, the provider measured the arm circumference of the patient’s nondominant upper arm and matched the patient with the correct cuff size per ABPM 7100 ©
specifications.
The providers then reviewed the manufacture’s patient instructions from the user manual
with their patients (see instructions in Appendix C). A copy of these instructions was signed by
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the patients and scanned into the patients’ charts. Each patient was also given a condensed
version of these instructions provided by the manufacturer to take home for reference (see a copy
in Appendix D). Patients also received an additional set of printed instructions written by the
DNP student in response to monitoring issues encountered during the first few patient visits (see
a copy in Appendix E). Patients were also asked to sign a borrower’s agreement, designed by
the DNP student and the practice manager (see the contract in Appendix F). They also received
a business card and number to reach someone should they have any issues during the monitoring
period. The DNP student was available by phone the entire 24-hours of each patient’s
monitoring period.
Next, BP measurements were performed via AOBP or manually, per provider preference,
on both arms to assess a typical office baseline. Each patient was then fitted with the Welch
Allyn 7100 ABPM©. The monitor was turned on and the provider confirmed that the battery
was ample for the duration of the monitoring. Obese patients were given a fresh set of batteries
and instruction regarding how to replace the batteries since the larger cuffs required more power
to inflate fully. The first ABPM reading was then taken. The providers compared this
measurement with the earlier two in-office readings for plausibility and comparability to the
office BPs. Measurements were repeated if there was a discrepancy between the ABPM and the
office measurements of more than 20 mm Hg systolic or diastolic. The patients were given a
journal and instructed to write down when they went to bed and when they woke up for the
purpose of determining dipper status, and when they took their antihypertensive(s), if any (see
copy of journal in Appendix G).
Patients were also instructed to write down any information they deemed pertinent to
monitoring including symptoms and activities. Patients were instructed to wear the monitor for a

IMPROVING HYPERTENSION MANAGEMENT

21

full 24 hours continuously, and to return the monitor and journal to the same office during
business hours as soon as possible after completion. The monitor was programmed to take
measurements automatically every15 minutes during the day (07:00 to 19:59) and every half an
hour at night (20:00 to 06:59). The BP readings were blinded to the patient when the monitor
was programmed. An alternative program was used for patients who worked second or third
shift. The same timing intervals were used, just with different timeframes. Once this initial setup visit was completed and the monitor was functioning, patients were scheduled to have a
follow-up appointment within the next week to receive their monitoring results. Patients were
instructed to bring their HBPM to the next appointment if they had one.
Once the monitor was returned, the DNP student downloaded the readings from the
monitor and generated a report for the providers to interpret. The monitor report and the
patients’ journals were scanned into their EMR by the office staff. A designated staff member
was responsible for cleaning the monitoring equipment per manufacturer’s instructions and
getting it ready to be used on the next patient. An area was designated for the monitors, BP
cuffs, manuals, and accessories to be stored.
At the second visit, the providers reviewed the results of the ABPM with the patients.
Each patient received a personalized treatment plan based on the ABPM results. All patients,
except those diagnosed with only WCH, received education on recommended lifestyle
modifications, including a handout on the DASH diet (National Heart, Lung, and Blood Institute,
2015) (see a copy in Appendix H). Patients were asked to complete a three-day diet diary and
log an activity or exercise on a form that is part of the DASH diet handout (the log page of the
handout was duplicated so each patient had three blank records). The patients also received a
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handout with logs from the American Heart Association (AHA) about HBPM (see a copy of
AHA handout in Appendix I).
If patients brought in their HBPMs, they were tested for accuracy against the office
measurements. Verification of the accuracy of the patients’ HBPMs was documented in each
patient’s EMR. If a patient did not bring it, he/she was instructed to bring it to the next
appointment. Patients who did not have a HBPM or who had a HBPM deemed inaccurate, were
provided with a handout created by the DNP student with information about purchasing a new
one (see a copy in Appendix J). Patients who stated that they could not afford a HBPM were
provided with a validated monitor by the practice.
Patients were instructed to check their BP once in the morning and once in the evening,
three times per week or more depending on provider preference, and to record these readings on
the AHA log provided to them. The patients’ providers then made a plan for follow-up per usual
standards of HTN care and JNC-8 recommendations. Any patients who were identified as
having WCH, and not having pre-hypertension or HTN, did not continue in the project. The
DNP student provided the patients’ providers with a questionnaire at each of their second office
visits to assess their early feedback. Patients were also asked to voluntarily complete a
questionnaire about their confidence in managing their HTN and about their lifestyle choices.
At the third visit, for prehypertension or HTN follow-up, patients were asked to give their
providers their HBPM logs and DASH dairies to review. Standard HTN care, using the JNC-8
guidelines as a reference, was provided. Reinforcement of lifestyle modifications per the
AHA/ACC guidelines were again provided as part of standard care. After each patient’s third
visit, the DNP student asked the providers to complete a questionnaire soliciting late feedback.
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Patients were also requested to complete the same questionnaires as they did on their second
visit.
During the entirety of the QI project, information about HTN diagnoses, medication
changes, BP readings, heart rates, weights, and other quantitative data deemed pertinent to their
standard HTN care was collected by the office staff and providers and remained confidential.
The DNP student had access to aggregated data for analysis to determine the impact of the
project on HTN management and office practices. Other information such as demographic data,
insurance information, and medical record numbers were kept anonymous throughout the
process.
Results
Outcomes
The aim of this QI project was to follow 50 patients through two to three PC HTN visits.
A total of 48 patients participated in at least one visit but due to patient dropout and time
constraints, 32 patients were followed to completion. Of the original 48 patients, twelve patients
had their third visit scheduled after the end of the project. Only four patients failed to follow-up.
Of the 32 completers, twenty-five patients with prehypertension or hypertension completed three
visits. Seven patients who were diagnosed with WCH were seen for two visits as planned.
Baseline characteristics of participants. The baseline characteristics of all 48
participants who took part in the QI project were collected at their first visit as shown in Table 1.
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Table 1
Baseline Characteristics of Participants (N=48)
Characteristic

M±SD or %*

Age in years
Female Sex
Caucasian Race
Height in inches
Weight in pounds
BMI kg/m2
Positive smoker status
Hypertension diagnosis
On hypertensive drugs
Number of antihypertensives
Hyperlipidemia
Diabetes
Chronic Kidney Disease
Heart Disease
Office SBP mm Hg
Office DBP mm Hg
[*Mean (M)± Standard Deviation
(SD) or Percent (%)]

52.15±11.65
64.6
100
66.17±3.51
199.16±52.49
31.79±7.30
10.4
52.08
47.9
0.81±0.98
64.6
14.6
0.0
14.6
142.67±14.91
84.54±8.34

Sixty-five percent (n = 31) of the participants were female. The participants ranged in
age from 20 years old to 74 years old; the mean age was 52.15 years (SD = 11.65). Their body
mass index (BMI) ranged from 20.90 kg/m2 to 58.50 kg/m2, mean 31.79 kg/m2 (SD = 7.30).
Fifty-two percent of the population (n = 25) had a pre-existing diagnosis of hypertension; 48%
were on one or more antihypertensives (n = 23). The participants’ BP was measured in each arm
at the first visit unless contraindicated. The two measurements were averaged, and the average
was used as their first visit BP. The participants’ systolic BP ranged from 111 mm Hg to 180
mm Hg; the mean was 142.67 mm Hg (SD = 14.91). Diastolic BP ranged from 68 mm Hg to
106 mm Hg with a mean of 84.54 mm Hg (SD = 83.4).
Provider, System, and Patient goals and objectives are listed with results’ metrics,
measures, and analysis of outcomes for each immediately following .
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Provider results.
Goal one. Providers will use data from ABPM to guide HTN diagnosis and treatment decisions.
Objectives
Expected outcomes
1.

Providers will find the ABPM readings
were influential in making decisions
regarding HTN diagnoses
2. Providers will find the ABPM readings
were influential in making decisions to not
start, start, stop, or change antihypertension
medications
3. Providers will be satisfied with the
implementation of ABPM

Providers will rate the ABPM readings as very influential
or extremely influential in making decisions regarding
HTN diagnoses
Providers will rate the ABPM readings as very influential
or extremely influential in making decisions regarding to
not start, start, stop, or change antihypertension
medications
Providers will provide positive feedback about the use of
ABPM in diagnosing and managing patients with HTN

Goal two. Providers will use data from HBPM to guide HTN diagnosis and treatment decisions.
Objectives
Expected outcomes
1.

Providers will find the HBPM readings
were influential in making decisions
regarding HTN diagnoses
2. Providers will find the HBPM readings
were influential in making decisions to not
start, start, stop, or change antihypertension
medications

Providers will rate the HBPM readings as very influential
or extremely influential in making decisions regarding
HTN diagnoses
Providers will rate the HBPM readings as very influential
or extremely influential in making decisions regarding to
not start, start, stop, or change antihypertension
medications

Goal three. Providers will use data from CPGs to guide HTN diagnosis and treatment decisions.
Objectives
Expected outcomes
1.

Providers will use JNC-8 guidelines as part
of their decision-making process in making
HTN diagnoses
2. Providers will use JNC-8 guidelines as part
of their decision-making process in not
starting, starting, changing, or stopping
antihypertensive medication
3. Providers will use the AHA/ACC guidelines
in forming lifestyle modification
recommendations for their patients

Providers will rate the JNC-8 guidelines as very
influential or extremely influential in making decisions
regarding HTN diagnoses
Providers will rate the JNC-8 guidelines as very
influential or extremely influential in making decisions
regarding to not start, start, stop, or change
antihypertension medications
Providers will rate the AHA/ACC guidelines as very
influential or extremely influential in making decisions
regarding to not start, start, stop, or change
antihypertension medications

Goal four. The QI project will have a positive impact on providers.
Objectives
Expected Outcomes
1.

Providers will be satisfied with the quality
improvement project

1.

Providers will report on surveys that the QI project
has been moderate to extremely influential in
managing HTN in their patients
2. Providers will provide positive feedback about the
elements of the project
3. Providers will express a desire to continue using
elements of the QI project in the future
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Providers were asked to complete an “early” questionnaire (see a copy in Appendix K)
and a “late” questionnaire (see a copy in appendix L) after each QI project participants’ second
and third visit, respectively. Providers were asked to rate how influential the various elements of
the QI project were in the diagnosis and treatment of their patients. Items were rated on a 5point Likert scale, 1-not at all influential, 2-slightly influential, 3-moderately influential, 4-very
influential, 5-extremely influential. Thirty-seven out of 44 questionnaires after visit two were
completed which is a response rate of 84.1%; 25 of 26 questionnaires were completed after the
third visit which is a response rate of 96.2%. The results of the early questionnaire are detailed
in Table 2, and the results of the late questionnaire are detailed in Table 3.
Table 2.
Early Provider Feedback (N = 37)
Item
How influential were the patient’s ABPM readings in making
a diagnosis regarding their BP?
How influential were the patient’s ABPM readings in the
decision to not start, start, or change an antihypertensive
medication?
How influential were the JNC-8 guidelines in making a
diagnosis regarding their BP?
How influential were the JNC-8 guidelines in the decision to
not start, start, or change an antihypertensive medication?
How influential were the AHA/ACC guidelines in forming
lifestyle recommendations for the patient?

Mean SD Median Range
4.70
0.88 5
1-5
4.70

0.88 5

1-5

4.86

0.35 5

4-5

4.89

0.31 5

4-5

4.76

0.64 5

2-5

Table 3.
Late Provider Feedback (N=25)
Item

Mean SD

Median Range

How influential were the patient’s HBPM readings in making
a diagnosis regarding their BP?
How influential were the patient’s HBPM readings in the
decision to not start, start, or change an antihypertensive
medication?
How influential were the JNC-8 guidelines in making a
diagnosis regarding their BP?
How influential were the JNC-8 guidelines in the decision to
not start, start, or change an antihypertensive medication?
How influential were the AHA/ACC guidelines in forming
lifestyle recommendations for the patient?
Overall, how influential has this QI project been in how you
manage hypertension in your patients?

4.67

0.87 5

2-5

4.67

0.87 5

2-5

4.67

0.76 5

2-5

4.75

0.68 5

2-5

4.75

0.61 5

3-5

4.83

0.08 5

4-5
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Providers found both types of blood pressure monitors to be influential in their decision
making. Based on early provider feedback after visit two, the providers found the ABPM
readings very influential to extremely influential in making a diagnosis regarding patient’s BP
based on a mean Likert score of 4.70 (SD = 0.88). They also found the ABPM readings very
influential to extremely influential in making medication changes, based on a mean Likert score
of 4.70 (SD = 0.88).
Based on late provider feedback after visit three, the providers found the HBPM readings
very influential to extremely influential in making a diagnosis regarding patient’s BP based on a
mean Likert score of 4.67 (SD = 0.87). They also found the HBPM readings very influential to
extremely influential in making medication changes, based on a mean Likert score of 4.67 (SD =
0.87). The two CPGs were also rated as influential in HTN management decision-making
process. The providers rated the JNC-8 guidelines as very influential to extremely influential in
making a BP diagnosis (M = 4.86, SD = 0.35) and in making treatment decisions (M = 4.89, SD
0.31) at the early visit.
The responses to the late questionnaire were similar to the early questionnaire. Providers
rated the JNC-8 guidelines very influential to extremely influential in making a diagnosis
regarding BP (M = 4.67, SD 0.76) and in making medication changes (M = 4.75, SD = 0.68).
Providers rated the AHA/ACC guidelines as very influential to extremely influential in forming
lifestyle modification recommendations for their patients on both the early questionnaire (M =
4.76, SD = 0.64) and late questionnaire (M = 4.75, SD 0.61). Overall, the providers found the
quality improvement project to be very influential to extremely influential in managing HTN in
their patients (M = 4.83, SD = 0.08).
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Space was left at the bottom of each survey and marked “recommendations/ feedback” to
solicit qualitative provider feedback. The practitioners gave the following feedback about the
ABPM, “great for detecting white coat hypertension” and “I found the patient's BP readings very
helpful when determining the best time to dose medications. This helped to avoid hypotension
episodes”. One provider liked using ABPM because she was “able to see the data and speak
with the patient with the actual results in front of us, makes the problem real”. Another provider
wrote, “Patients realized that their blood pressure was an important topic, they felt that we cared.
Most of the time we just ask them to ‘keep track of your blood pressure’ and ‘call us’, but this
time they actually got to wear a monitor for 24 hours, ‘it was amazing’ they said.” In another
comment, the provider wrote, “Being able to analyze the data and make changes: start or
discontinue a medication based on the results were satisfying and I consider good patient care.”
Providers gave the following feedback about the AHA/ACC guidelines, including the
education packet on the DASH diet, “Education patients received after diagnosis of hypertension
was extremely beneficial. Patients made numerous lifestyle changes to effectively manage blood
pressure. Numerous patients reported better understanding and compliance with DASH diet”.
One practitioner wrote, “the DNP student spent almost 1 hour with each patient, this
education/time is invaluable. Usually in a busy primary care practice we don't have 1 hour to
spend with each patient, it was nice to have this resource.”
Goal five. The QI project will decrease clinical inertia.
Objectives
Expected outcomes
1. Project patients who have suspected HTN,
prehypertension, or an established diagnosis
of HTN will have their HTN status
addressed
2. Medication changes will be made if patients
are not meeting recommended goals of
HTN therapy

Patients will receive a diagnosis regarding their HTN
status after ABPM

1.

Medication changes will be made in response to
ABPM results which show uncontrolled HTN
2. Medication changes will be made in response to
HBPM results which show uncontrolled HTN
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This project was successful at combating clinical inertia. All the patients who returned
for follow-up had their HTN status addressed. Table 4 outlines the diagnoses made at visit two.
Table 4
Diagnosis at Visit Two (n=47)
Item

n or %

Hypertension controlled on antihypertensive
Hypertension uncontrolled on antihypertensive
New diagnosis of uncontrolled HTN
White coat hypertension
Prehypertension
Episodic hypotension on antihypertensive
Episodic bradycardia on antihypertensive
Percent of patients with a change in hypertensive status at visit 2
Percent of patients with a change in antihypertensive medication at visit 2
Percent of patients with newly diagnosed HTN or uncontrolled HTN with a change in
antihypertensive medication at visit 2.
Medication changes made
No change made
New antihypertensive class added or started
Dose of current antihypertensive changed
Antihypertensive discontinued
Drug class changed

11
9
12
7
6
1
1
76.6
51.1
100
23
18
4
1
1

At the second visit, patients had their HTN status reevaluated based on their ABPM
results. The ABPM manufacturer’s suggested cutoff of either SBP ≥ 135 mm Hg or DBP ≥ 85
was used as the cutoff for new diagnosis of HTN. The JNC-8 guideline goals for HTN control
were used for patients already on an antihypertensive. For patients with unsuccessful ABPM
results, HTN status was evaluated based on the available ABPM readings, the patients’ recent inoffice BP measurements, and the clinical judgment of each provider. Forty-seven of the 48
patients (97.9%) who underwent ABPM had their HTN status addressed at their second visit.
One patient with unsuccessful ABPM failed to follow-up.
A total of 21 patients were found to have uncontrolled HTN; 12 patients were newly
diagnosed with HTN and nine patients were found to have uncontrolled HTN on their current
antihypertensive regimen. All of the patients with uncontrolled HTN had antihypertensive
medication added or intensified. Two patients were found to be having side effects from their
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antihypertensive therapy. In one case, a patient with controlled BP who showed episodes of
hypotension on his ABPM report was able to come off his antihypertensive. In another case, a
patient with intermittent bradycardia had her dose of beta blocker switched to another drug class.
Based on the ABPM results seven patients were diagnosed as having white coat
hypertension (WCH). Some patients had elevated BP averages in the prehypertensive range and
were diagnosed as prehypertensive rather than WCH. Eleven patients who underwent ABPM to
assess their HTN control on antihypertensives were found to have controlled BP and no changes
were made to their medication regimen.
At visit three, patients’ HBPM and/or the patient’s in-office BP readings were used to
evaluate their BP control. Of the twenty-five patients who were seen for a third visit, 20 had
controlled BP and five had uncontrolled BP. Table 5 outlines the medication changes made.
Table 5.
Blood Pressure Control and Medication Changes at Visit Three (n=25)
Item

n or %

Percent of patients with hypertension controlled on antihypertensive
Percent of patients with hypertension uncontrolled on
antihypertensive
Patients with a change in antihypertensive medication at visit 2
Medication changes made
New antihypertensive class added
Dose of current antihypertensive increased
Antihypertensive discontinued
Drug class changed

80
20
5
1
1
1
2

One-hundred percent of the patients with uncontrolled BP at visit 3 had their antihypertensives
addressed. Two patients who were started on an angiotensin converting enzyme inhibitors were
switched to angiotensin II receptor blockers at their third visit after they developed a cough.
Timely follow-up is also important in decreasing clinical inertia. The mean time between
appointment one for ABPM set-up and appointment two was 7.64 days (SD = 9.33). This is
close to the planned timeframe of within a week. The mean time from visit two to visit three was
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31.92 day (SD = 11.18). Patients who had a change in their medication at visit two had a
slightly faster time to follow-up with a mean of 29.30 days (SD = 8.41). The mean time between
visit one and visit three was 38.14 days (SD = 10.91). Moreover, in each second and third
patient visits, the patient’s HTN status and medications were addressed. At visit two more than
half of all patients (51.5%) had a medication change made based on their ABPM results.
System results.
Goal five. Patients will undergo ABPM to ascertain hypertension status.
Objectives

Expected outcomes

1.

1. Patients will wear the monitor for 24 hours.
2. The device will successfully capture ≥ 70% of
attempted readings

Patients who meet the inclusion/exclusion
criteria will undergo 24-hours of ABPM

Goal six. Patients with HTN will monitor their BP at home.
Objectives
1.

Patients will use a validated HBPM to
monitor their HTN at home.

Expected outcomes
1.

2.
3.
4.
5.

Patients will bring their monitor to their second or
third appointment to have it checked by the provider
for accuracy
Patients will use a validated HBPM to measure their
BP at home
Patients will complete a BP log as directed by their
provider
Patients will bring their BP log to their third
appointment
Patient compliance with this will be documented in
their medical record

All 48 patients who met the inclusion/exclusion criteria presented to their first visit for
set-up of ABPM to assess their hypertensive status. A total of 37 patients went on to have
successful 24-hour ABPM, which was defined as wearing the monitor for a minimum of 20
hours and ≥ 70% success rate in the total number of attempted BP measurements. A total of 10
patients had unsuccessful ABPM. Overall, 77% of patients successfully underwent ABPM. The
characteristics of the unsuccessful and successful ABPM reports are displayed in Tables 6 and 7,
respectively.
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Table 6.
Characteristics of Unsuccessful AMBP
Item

M±SD

Overall SBP mm Hg (n=9)
Overall DBP (mm Hg) (n=9)
Awake SBP (mm Hg) (n=9)
Awake DBP (mm Hg) (n=9)
Asleep SBP (mm Hg) (n=8)
Asleep SBP (mm Hg) (n=8)
Dipper status (n=9)
Percentile classified as non-dipper
Percentile classified as dipper
Unable to determine
Time worn (hours: minutes) (n=9)
Total number of readings (n=9)
Percentile of successful readings

130.7±13.2
78.8±10.0
134.2±12.2
81.7±8.7
121.9±18.0
71.8±14.9
33.3
33.3
33.3
19:23±5:02
43.2±14.5
60.3±19.5

Table 7.
Characteristics of Successful AMBP (n=37)
Item

M±SD or %

Overall SBP (mm Hg)
Overall DBP (mm Hg)
Awake SBP (mm Hg)
Awake DBP (mm Hg)
Asleep SBP (mm Hg)
Asleep SBP (mm Hg)
Dipper status
Percentile classified as non-dipper
Percentile classified as dipper
Time worn (hours: minutes)
Total number of readings
Percentile of successful readings

132.2±11.7
82.3±9.3
136.2±12.4
85.0±10.0
119.3±12.1
70.4±13.1
61.1
38.9
23:46±: 03:00
73.0±9.4
90.0±7.5

Two patients were unable to tolerate the monitoring. One patient was unable to tolerate
the monitor before leaving the office, stating that her arm hurt and felt numb between readings.
The symptoms stopped once the monitor was discontinued. No data was recorded from her
monitor. Another patient with pre-existing shoulder pain discontinued the monitoring after 15
hours because it was increasing her pain. She reported that her shoulder returned to baseline
after discontinuation. Two patients discontinued their monitoring earlier than the 20-hour mark
because they were getting multiple error messages.
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An additional six patients did not reach the 70% successful readings cut-off because of
various measurement errors. None of these nine patients with measurement issues called the oncall number to troubleshoot the monitor as instructed. Eight of the patients knew they were
having errors but didn’t call the on-call person because they did not think it was necessary or
they did not want to bother the on-call person. One patient was unaware the device was having
errors, which occurred while he was asleep.

Four patients with successful ABPM reports also

reported multiple measurement errors. In each case they called the DNP student and the issues
were able to be addressed over the phone. Overall, 24 patients reported tolerating the monitoring
without any issues. Three patients reported difficulty sleeping with the monitor, three reported
that the monitoring caused them mild anxiety, and three patients reported that it interfered with
their daily activities. One patient reported a mild rash under the BP cuff that resolved once the
BP cuff was removed.
Of the 47 patients who were seen for a second visit, 34 patients had either a pre-existing
diagnosis of HTN or new diagnosis of HTN. All of these patients were asked to monitor their
BP at home with a validated HBPM. These patients were also asked to bring their monitor in to
have it validated as accurate by their provider. Of the 26 patients who were seen for a third visit,
21 patients (80.8%) had brought in a HBPM, had its accuracy validated, and the check of the
monitor was documented in their EMR. Twelve patients had not yet brought in a monitor for
validation as documented in their EMR. One patient had no documentation about the status of
their HBPM. Eighteen of the 26 patients (69.2%) brought in the completed log of their HBPM
readings. Of the eight patients who did not, six of them stated they forgot to bring it in (23.1%)
and two patients (7.7%) stated they had not yet acquired a HBPM. All completed HBPM logs
were scanned into the patient’s EMR.
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Patient results.
Goal seven. Patients will experience greater self-efficacy in the management of their
hypertension.
Objectives
Expected outcomes
1.

Patients will receive lifestyle modification
education aimed at improving BP control as
part of their visit(s) with provider

2.

Patients will report confidence in managing
their prehypertension/HTN.

3. Over the course of the project, patients will
adopt one or more lifestyle modifications
aimed at improving BP control

1.

Lifestyle modification education will be provided
and documented at each patient encounter
2. Patients will complete three days of food and activity
journaling between visit two and three
1. Patients will report high to complete confidence in
their ability to manage the self-efficacy tasks
associated with their prehypertension/hypertension
after their third visit
2. Patient will report increased confidence in their
ability to manage their BP at visit 3 compared to visit
2
Patients will report adopting lifestyle modifications
during visit three

Goal eight. Patients will experience improved health outcomes.
Objectives

Expected outcomes

1. Patients will experience improved BP control

The number of patients with undiagnosed or
uncontrolled HTN will be reduced
Some overweight patients will lose weight at visit three
compared to visit one

2. Overweight patients will experience weight loss
if overweight or obese

Goal nine. The project will have a positive impact on the practice and its patients.
Objectives

Expected outcomes

1. Patients will be satisfied with their HTN
management

Patients will state satisfaction with their HTN care during
visits

One hundred percent of patients who were determined to be prehypertensive or
hypertensive had lifestyle modification (LM) education aimed at reduced BP documented as part
of their second and third visits. These patients also all received the DASH diet handout and the
American Heart Association BP log as planned. Patients were asked to journal three days of
food intake and activity on the log provided in the DASH diet handout. Patient were instructed
to choose any three days between visit two and visit three to complete this activity. Half of the
patients seen for a third visit completed the DASH diet logs as requested. Thirteen patients
either did not complete it or forgot to bring it with them to their appointment. Several patients
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commented that tracking their daily food intake helped them identify sources of sodium in their
diet. Two patients completed more than the requested three days’ worth of logs.
To assess patients’ self-efficacy in managing their HTN, patients classified as prehypertensive or hypertensive were asked at their second and third visit to complete a
questionnaire. The questionnaires were identical except the questionnaire given during the
second visit was labeled “early’” and the questionnaire given during the third visit was marked
“late”. The Self-Efficacy to Manage Hypertension scale (see scale and details in Appendix M)
has been used in previous studies and is considered to be valid tool for measuring patient’s levels
of self-efficacy (Warren-Findlow, Seymour, & Brunner Huber, 2012) The response rate after the
second visit was 68.2%. The rate of reply after the third visit was 53.8%. Table 8 displays the
results after visit two. The results of the late questionnaire are shown in Table 9.
Table 8.
Early Patient Confidence (n=30)
Item

M±SD

Having high blood pressure often means doing different tasks and activities to manage your
condition. How confident are you that you can do all the things necessary to manage your high
blood pressure on a regular basis?
How confident are you that you can judge when changes in your high blood pressure mean you
should visit a doctor?
How confident are you that you can do the different tasks and activities needed to manage your
high blood pressure so as to reduce your need to see a doctor?
How confident are you that you can reduce the emotional distress caused by your high blood
pressure so that it does not affect your everyday life?
How confident are you that you can do things other than just taking medication to reduce how
much your high blood pressure affects your everyday

3.7±1.2

4.0±1.0
3.8±1.0
3.2±1.2
3.8±0.9
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Table 9.
Late Patient Confidence (n=14)
Item

M±SD

Having high blood pressure often means doing different tasks and activities to manage your
condition. How confident are you that you can do all the things necessary to manage your high
blood pressure on a regular basis?
How confident are you that you can judge when changes in your high blood pressure mean you
should visit a doctor?
How confident are you that you can do the different tasks and activities needed to manage your
high blood pressure so as to reduce your need to see a doctor?
How confident are you that you can reduce the emotional distress caused by your high blood
pressure so that it does not affect your everyday life?
How confident are you that you can do things other than just taking medication to reduce how
much your high blood pressure affects your everyday

4.2±0.7

4.4±0.6
4.2±0.8
3.7±1.1
4.3±0.7

At the end of visit two and again at the end of visit three, patients were asked to rate their
confidence in managing the variables that affect their BP management using the Self-Efficacy to
Manage Hypertension scale. A five-item Likert scale was used with the following responses 1no confidence, 2- slight confidence, 3- moderate confidence, 4- high confidence, and 5- complete
confidence. For the purpose of this QI project, a score of 4 or greater was considered to
constitute good self-efficacy.
Patients were found to have good self-efficacy in one of the five areas. Patients reported
high confidence (M = 4.0, SD 1.0) to the question, “How confident are you that you can judge
when changes in your high blood pressure mean you should visit a doctor”. After the third visit,
patients reported increased confidence on all five items compared to visit two although the
differences did not reach the level of statistical significance. On the late questionnaire patients
reported having good self-efficacy in four of the five items. Patients’ lowest self-efficacy scores
on both late and earlier questionnaires was in response to the question, “How confident are you
that you can reduce the emotional distress caused by your high blood pressure so that it does not
affect your everyday life”.
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Six self-care behaviors have been identified as being associated with improved blood
pressure control, especially when two or more of these behaviors are used together (Chobanian et
al., 2003). The six practices are maintaining a healthy weight, adopting a healthy eating plan
such as the DASH diet, restricting dietary sodium, engaging in regular physical activity, limiting
alcohol consumption, and avoiding tobacco exposure (Chobanian et al., 2003). Lifestyle
modification teaching was provided at each of the visits. As part of their care, patients were also
asked about these self-care behaviors at each of their visits. At the third visit, 53.8% of patients
(n = 14) reported that they had adopted one or more of these self-care behaviors since visit two.
Eight patients reported actively trying to lose weight, including one patient who joined a
medically-supervised weight loss program. Ten patients reported that they had decreased their
sodium intake. Eight patients reported adopting a healthy eating plan. Four patients reported
adopting the DASH diet plan specifically. One of the patients reporting seeing a nutritionist to
help her assume the DASH diet. Another of the patients reporting that she liked the information
given to her about the DASH diet and it prompted her to buy a book about the DASH diet to
learn more. Five patients reported that they had increased their level of physical activity. One
patient reported decreased alcohol consumption. One patient reported smoking cessation.
Another two patients reported reducing the number of cigarettes they smoked. Both patients
made plans to quit and started medications to help them quit smoking.
A greater than 50% reduction in the rate of uncontrolled HTN was observed. The results
are displayed in Table 10.
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Table 10.
Two-sample T-Test and Confidence Interval of Difference in Percentage of Uncontrolled Blood
Pressure at Visit 2 and Visit 3
Item
N M
SD
SE
Uncontrolled blood pressure -visit 2
Uncontrolled blood pressure -visit 3
t(58) = 2.25, p = 0.028, 95%
95% CI for difference [0.027, 0.466]

47
25

0.447
0.200

0.503
0.408

0.073
0.082

During the QI project a statistical significant decrease in the percentage of patients with
uncontrolled HTN was observed. A two-sample T-test showed that the proportion of patients
with uncontrolled HTN at visit two (44.7%) versus the proportion of patients with uncontrolled
HTN at visit three (20%) was statistically significantly different, t(58) = 2.25, p = 0.028, 95% CI
[0.027, 0.466].
The patients who participated in the QI project did not lose a statistically significant
amount of weight. The patients’ weights at each visit are compared in Table 11.
Table 11.
Comparison of Weights in Pounds at Visit 1 and Visit 3
Value Visit One Visit Three Change
n
M
SD
Min
Max

48
199.16
52.49
118
396.2

26
202.6
58.8
126.2
396.2

n/a
2.12
6.86
-14.80
16.80

A two sample T-test of the patients’ weights at visit one (n = 48, M = 199.16 pounds, SD
= 52.49) and visit three (n = 26, M = 202.6 pounds, SD = 58.8) showed that the patients’ weights
did not significantly between the visits; t (44) = -0.25, p = 0.807, 95% CI [-31.6, 24.7].
Many of the participants in the QI project stated satisfaction with their HTN care. One
patient who recently joined the practice stated, “my other doctor always told me not to worry
about my BP readings. I am glad I switched because you are telling me I do have HTN and I do
need treatment”. Another patient also expressed appreciation for the provider’s attention to
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elevated BP readings, “I didn’t think anything of my BP readings, I am happy that you decided
to have me wear the monitor so I could be diagnosed correctly”. Patients also expressed
satisfaction with the lifestyle modification teaching. One patient stated, “no one has ever taken
the time to explain how I can improve my BP without medication. Thank you”. Another patient
stated, “no one has ever shown me how to read the label to find out how much salt is in my food.
I will be checking this from now on”. Another patient stated, “I loved the packet you gave me
about healthy eating. I have been trying to follow it every day”. Patient also stated satisfaction
with the use of ABPM and HBPM readings in making treatment decisions. One patient stated, “I
feel better having my medication increased now that I know what my readings at home are”.
Another stated, “I like that my medication is based more than one reading”. Several patients
who were diagnosed with WCH stated satisfaction that they could prove they did not have HTN,
one stated, “I know my BP is only elevated when I go to the doctor”. One patient who was
diagnosed with WCH stated he was very pleased he had the opportunity to wear the ABPM
because it allowed him to get his Department of Transportation card renewed for two years
instead of one year.
Facilitators and Barriers
The providers and the practice site offered few barriers to implementation of this QI
project. The practice owner is also one of the practitioners in the practice and was vested in the
outcome of this project. She was also intimately involved in the development and
implementation of this project. Additionally, as an independently owned and operated practice,
with no physician oversight or complex organizational structure, there were few obstacles to
implementing the project. In New Hampshire, nurse practitioners have full, independent practice
and prescriptive authority (New Hampshire Board of Nursing, n.d.). Additionally, the DNP
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student used provider and staff feedback to make ongoing adjustments to plan as necessary.
There were no barriers or resistance from the providers. Each seemed to welcome the project,
and they were all open to the changes implemented.
The biggest barrier, from a system’s perspective, was purchasing and learning to use the
ABPM machines. It was hoped that the companion CarioPerfect© software would allow for
integration of the reports seamlessly into the practice’s electronic medical record (EMR).
Despite technical support from both Welch Allyn and the EMR company, the systems could not
be integrated. This barrier was overcome by generating the ABPM reports, printing them and
scanning them into each patient’s EMR.
Another barrier was the recruitment of patients who fit the desired sample. Initially
recruitment was slow as the project started right before the holiday season and patients were
reluctant to schedule additional appointments. This obstacle was overcome by time and by the
providers’ active involvement in identifying patients who would benefit from ABPM. Once the
providers received the results of the first few patients’ ABPM, they perceived the benefit and
were eager to have more of their patients undergo the monitoring. The practice also had many
ways of reaching out to patients- in person, phone calls, and through electronic patient portals.
It was anticipated that arm size could also be a barrier to implementing ABPM. There
was a concern with having two monitors and only two cuffs for each would limit the ability to
match patients to the appropriately sized cuff. Ahern and colleagues (2012) solved this issue by
restricting participants in their study to those with an arm circumference of 9 to 17 inches. It was
determined that excluding participants because of arm circumference could be problematic, since
if obese patients might be excluded, and they may be most likely to benefit from targeted
interventions. This was overcome by buying additional BP cuffs so that two cuffs of every size
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from small adult to large adult were always available. This added additional expense and
delayed the launch of the project by a few days.
There were also barriers to the implementation of HBPM. Many patients did not have a
HBPM or had one that was not reliable. Some patients were resistant to having to monitor their
BP at home. This was overcome by explaining the benefits of having multiple BP readings on
which to make decisions about their medications. Many patients were eager to know what types
of HBPM they should purchase. It was for this reason a handout was created with information
about buying HBPM. Another potential issue with HBPM that was not foreseen was the
reliability of patient-reported BP measurements. One study found that more than 30% of
patients underreported blood pressure readings (Mengden, 1998). There is no way to know if the
readings the patients reported at their third visit were an accurate representation of their home
BP. This can be overcome with newer automated HBPMs, which will store readings. Clinicians
could have had the patients bring their monitor to each visit and directly retrieved the readings
from the device to avoid BP misreporting.
Patient barriers included failure to report or recognize ABPM measurement errors. It was
anticipated that not all patients would tolerate the ABPM. To maximize the number of patients
who would, detailed instructions were given both verbally and in written form. Additionally,
someone was available 24 hours a day by phone. Patients were encouraged during monitor setup to call with any issues. Despite this, several patients were unable to undergo successful
ABPM because of measurement errors that were avoidable or correctable such as errors caused
by frequent movement, kinked tubing, or loose connections.
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Discussion/Interpretations
The benefits and obstacles of implementing ABPM observed during the DNP project
were similar to those expressed in the literature. Overall, the providers and the patients
expressed satisfaction with the process. Patients reported some irritation with wearing the
monitors but most felt that the temporary inconvenience was outweighed by the results provided.
Patients and providers both reported satisfaction and confidence in knowing exactly what the
patients’ HTN status was based on the many readings and results furnished by the monitor. The
providers reported increased comfort in making medication changes based on the results.
Patients also seemed more confident in the diagnosis they were receiving. Many of them
expressed the sentiment that they couldn’t argue the results.
The DNP project was also successful in overcoming clinical inertia. The providers
expressed increased confidence in their diagnosis and treatment decision-making abilities with
the added information gleaned from the ABPM reports, patients’ HBPM logs, and clinical
practice guidelines. Improving the believability of the BP readings upon which providers base
their diagnosis and treatment decisions may be a key component combating clinical inertia. This
QI project was successful in overcoming many provider, system, and patient barriers. The main
component of the project that was completely new to the practice was the implementation of
ABPM.
The practice had already been using HBPM as a means for assessing patients’ HTN
status. Through this QI initiative, HBPM and logging were able to be used in a more structured
way that seemed to improve the usefulness of the readings in making diagnosis and treatment
decisions. First, having all the patients bring their monitors in for validation of their accuracy
likely increased the providers’ belief in the home readings provided. Second, the AHA blood
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pressure handout provided directions and a structured format for measuring and recording BP.
Also, patients were informed that their HBPM reading would be used to inform future treatment
decisions. It is believed that increasing the use of HBPM increases the patients’ involvement in
the management of their disease and can improve patients’ sense of empowerment (Filippi et al.,
2013).
While AMPB may be superior to HBPM, HBPM is still of particular importance in
treating HTN over the long-term as it is an inexpensive, readily available, and convenient
method of measuring BP for most patients. HBPM also eliminates the white coat effect and it
has the potential to trend BP across longer periods of time than office monitoring or ABPM
(Jones et al., 2013). Using HBPM as an adjunct to ABPM, and through the standardization of
the HBPM process achieved during this QI initiative, the reliability of HBPM readings were
increased. This increased the usefulness of the HBPM readings to the providers in making
diagnosis and treatment decision regarding patients’ HTN. This project shows that patients
benefit from specific instructions regarding HBPM- what monitors to use, how to correctly take
a measurement, how often to take measurements, and how to create a log. Telling patients to
“measure your BP” is likely not enough direction.
The DNP project results also highlighted the need to address patients who fall into the
category of being prehypertensive. It is estimated that nearly one in three American adults fall
into this category (Mozaffarian et al., 2016). Several patients included in the project had ABPM
readings that were too low to be considered HTN but too high to call WCH in the providers’
clinical judgment. The course of action proved to be provider dependent, which is hard to
standardize. Some providers noted the patient’s pre-hypertensive status but arranged no further
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follow-up. While other providers had the patient begin monitoring their BP at home and
provided the patients with lifestyle modification education.
Prehypertension is linked to an increased risk of cardiovascular events and the
development of HTN (Kaplan, 2016). As such, an important part of improving the quality of
HTN care should include identifying and initiating nonpharmacological treatment for patients
who fall into this category. It may also be beneficial to stratify prehypertensive the patients who
are at greater HTN risk. Instituting clinical tools such as the Framingham Hypertension Risk
Prediction Score may be useful in identifying the patients who are most likely to develop HTN
(Parikh et al., 2008). Additionally, this project showed that future QI endeavors aimed at HTN
should include standardizing the care of patients who fall into this category.
Self-management is an important factor in controlling BP as HTN is a treatable,
manageable disease (Crowley, Grubber, Olsen, & Bosworth, 2013). Many patients who
participated in this project made positive lifestyle modifications aimed at improving their HTN.
The timeframe of this QI project was too short to know if any of the lifestyle modification
education and patient supports provided will have a long-term positive impact. The patients who
participated in this program varied considerably in their participation in the six self-care
activities described in the JNC-7 guidelines (Chobanian et al., 2003).
Patients reported many personal barriers to implementing lifestyle modifications
including the cost of fresh fruits and vegetables, the difficulty of exercising in the winter, the
resistance of their spouse to changing eating patterns, and lack of desire to change behaviors.
For example, some patients liked the DASH diet handout and made lifestyle modification based
on its contents. Other patients did not find it helpful at all. This observation underlines the need
for providers to individualize patient education and treatment strategies aimed at lifestyle
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modification. Future research exploring methods that can be used to tailor patient education to
maximize patients’ self-management of their HTN is recommended.
This QI project had the unexpected result of picking up problems that might have gone
unnoticed. The DNP student and providers checked to make sure each patient had a recent
electrocardiogram (EKG) and recent labs (6 to 12 months depending on the provider). Forty
percent of patients had no EKG on record within last year. Nineteen EKGs were performed at
visit two. Three EKGs were abnormal. Stress tests were ordered and completed. Two were
positive; both were referred to cardiology for further workup. Twenty-three percent of patients
did not have recent labs; full panels were ordered for these patients. This project was designed to
provide comprehensive HTN management. Multifaceted QI projects aimed at HTN have the
potential to improve overall cardiovascular care.
The results of this QI project may not generalizable to other populations. First, patients
were individually selected by the providers based on a questionable HTN status, which may have
led to the high percentage of patients who had a new diagnosis or medication change. Second,
the population was specific to this practice consisting of only Caucasian patients with insurance.
Third, the project timeframe was limited to only four months. Some results such as weight loss
and adherence to lifestyle modifications are best observed over longer periods of time. However,
this project does reinforce the benefits of careful blood pressure monitoring of at risk patients in
the primary care system.
Conclusion
Using the Chronic Care Model as a framework, the DNP student was able to complete a
complex, multifaceted QI project that spanned four months and was able to overcome some of
the provider, system, and patient barriers to improving HTN detection and management in one
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large primary care practice. The DNP student was successful in overcoming provider clinical
inertia by improving the amount and quality of the evidence practice providers used in making
diagnosis and treatment decisions. The addition of ambulatory blood pressure monitoring in the
primary care setting proved to be beneficial in helping providers make determinations about
patients’ HTN status. Increased patients’ education and involvement in the management of their
HTN proved useful for some patients. As a result, more than half of the patients who
participated in the project obtained control of their hypertension.
This DNP project helped to identify some of these barriers that can be addressed in future
HTN QI endeavors and future research. Based on the results of this project, it is evident a
comprehensive, multifaceted approach addressing all domains of the healthcare system must be
used to improve the quality of HTN care in the United States. Future hypertension quality
improvement efforts must address all the aforementioned facets within each of the provider,
system, and patient domains that contribute to the continuing health crisis of uncontrolled high
blood pressure in the United States.
The large primary practice where this project was implemented plans to continue the
project as implemented. This project write-up using the Doctor of Nursing Practice Scholarly
Project framework will be shared via student presentation at UMass and published via
ScholarWorks© at the UMASS Amherst library. Additionally, the abstract of this project will be
submitted for inclusion at several national conferences including the 2017 DNP conference and
the 2017 International Council of Nurses Congress.
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Appendix A
Schema of the Chronic Care Model

Figure 1. The Chronic Care Model (Improving Chronic Illness Care, 2016).
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Appendix B
Patient Eligibility Checklist*
Patient name:
Inclusion Criteria

Meets (check mark indicates that patient
meets criteria)

Aged 19 to 74 years
Suspected hypertension, prehypertension, or
established diagnosis of hypertension
Existing practice patient
English speaking
Literate
Private or public health insurance
Physically able to measure their blood pressure
at home
Upper arm circumference able to be matched
with an appropriate-sized ABP monitor cuff
Exclusion criteria
Pregnancy
Hypertension managed by a specialist
Cognitively impaired
Heart arrhythmia
Implanted defibrillator/pacemaker
Medical contraindication(s) to repeated blood
pressure measurement in the patient's nondominant upper arm such as a history of
mastectomy, poor circulation, the presence of a
wound, or arteriovenous shunt

Provider signature

DNP student signature
*DNP student created document

Does Not Meet (Check mark indicates the
absence of exclusion criteria)
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Appendix C

Manufacture’s Patient Instructions
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These are the patient instructions from the ABPM manual that were reviewed with the patient by
the provider (Welch Allyn, 2014a).
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Appendix D
Written Patient Instructions

This is a copy of the written instructions provided to the patient (Welch Allyn, 2014b).
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Appendix E
Additional Ambulatory Blood Pressure Monitoring Instructions*
•

Please make sure to write down the name, dose, and time of any antihypertensive
medications you are taking in your Patient Diary

•

If you enter any activity or symptoms into the Patient Diary, or hit the monitor event
button, make sure to write down the time, including AM or PM so we can match the
events to your blood pressure at the time

•

Someone will be available by phone at all times during your monitoring, do not hesitate
to call if you are experiencing any issues or concerns during the monitoring process

•

If you are getting frequent error messages or more than two error messages in a row,
please call so we can trouble shoot the monitor over the phone and avoid having to repeat
the test

•

When you return the monitor, please make sure to return your folder and Patient Diary,
along with the monitor and its components

•

It is extremely important to push the day/night button when you are going to bed (to
sleep), and again upon waking

•

The monitor must be worn for a full 24 hours

•

Please return the monitor at the arranged time and location

•

Please bring your home blood pressure monitor (if you have one) to your next
appointment

*DNP student created
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Appendix F
Borrower’s Agreement*
OWNER:
BORROWER:
Contact number:
Date lent:
Date due for return:
EQUIPMENT: Welch Allyn 7100 Ambulatory Blood Pressure Monitor, Welch Allyn blood pressure cuff, and carrying case.

TERMS AND CONDITIONS:

1. The borrower shall keep the equipment in a good state of repair, normal wear and tear excepted. The borrower shall read and follow
manufacturer’s instructions for use and care of the device prior to borrowing the device. The borrower will use the device in accordance with the
manufacturer’s specifications and operation instructions.

2. The borrower shall pay the owner full compensation for replacement and/or repair of any equipment which is not returned because it is lost or
stolen or any equipment which is damaged and in need of repair to put it into the same condition it was in at the time of rental, normal wear and
tear excepted.

3. The equipment shall be returned to owner at the borrower’s risk, cost, and expense. If the equipment is not returned during or at the end of the
term, the borrower will be responsible for the replacement cost of the equipment.

4. The borrower indemnifies and holds the owner harmless for all injuries or damage of any kind related to the use of this device.

5. The borrower shall pay all reasonable attorney and other fees, the expenses and costs incurred by owner in protection its rights under this
agreement and for any action taken owner to collect any amounts due the owner under this agreement.

6. The practice takes responsibility to ensure the borrower understands how the equipment works, how to operate it safely, signs of malfunction,
and how to prevent damage to the equipment as outlined by the manufacturer’s operating instructions. Someone from the practice will be
available by phone at all times for the duration of monitoring.

Date:

Borrower:

DNP student created
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Appendix G
Patient Journal

(Welch Allyn, 2014b)
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Appendix H
DASH Diet Handout
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(National Heart, Lung, and Blood Institute, 2015)
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Appendix I
Home Blood Pressure Monitoring Handout
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(American Heart Association, 2012)
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Appendix J
Home Blood Pressure Monitor Purchasing Guide*

*DNP student created with information from American Heart Association (2016)
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Appendix K
Early Provider Survey

How influential were the
patient’s ABPM readings in
making a diagnosis regarding
their BP?
How influential were the
patient’s ABPM readings in the
decision to not start, start, or
change an antihypertensive
medication?
How influential were the JNC-8
guidelines in making a diagnosis
regarding their BP?
How influential were the JNC-8
guidelines in the decision to not
start, start, or change an
antihypertensive medication?
How influential were the
AHA/ACC guidelines in forming
lifestyle recommendations for the
patient?

Not at All
Influential

Slightly
Influential

Moderately
Influential

Very
Influential

Extremely
Influential

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Recommendations/feedback:
Note: This is the DNP student created provider questionnaire given to each provider after each patient’s second
visit. The providers were asked to rate how influential each part of the quality improvement project were in their
decision-making process with that particular patient on a 5-point Likert scale with 1-not at all influential, 2-slightly
influential, 3-moderately influential, 4-very influential, 5-extremely influential. Providers were instructed to write
any recommendations or feedback about the project in the blank space at the bottom of each survey.
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Appendix L
Late Provider Survey

How influential were the
patient’s ABPM readings in
making a diagnosis regarding
their BP?
How influential were the
patient’s ABPM readings in the
decision to not start, start, or
change an antihypertensive
medication?
How influential were the JNC-8
guidelines in making a
diagnosis regarding their BP?
How influential were the JNC-8
guidelines in the decision to not
start, start, or change an
antihypertensive medication?
How influential were the
AHA/ACC guidelines in
forming lifestyle
recommendations for the
patient?

Overall, how influential has this
QI project been in how you
manage hypertension in your
patients?

Not at All
Influential

Slightly
Influential

Moderately
Influential

Very
Influential

Extremely
Influential

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Recommendations/feedback:
Note: This is the DNP student created provider questionnaire given to each provider after each patient’s third visit.
The providers were asked to rate how influential each part of the quality improvement project were in their decisionmaking process with that particular patient on a 5-point Likert scale with 1-not at all influential, 2-slightly
influential, 3-moderately influential, 4-very influential, 5-extremely influential. Providers were instructed to write
any recommendations or feedback about the project in the blank space at the bottom of each survey.
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Appendix M
Self-Efficacy to Manage Hypertension

1. Having high blood pressure often means doing
different tasks and activities to manage your condition.
How confident are you that you can do all the things
necessary to manage your high blood pressure on a
regular basis?
2. How confident are you that you can judge when
changes in your high blood pressure mean you should
visit a doctor?
3. How confident are you that you can do the different
tasks and activities needed to manage your high blood
pressure so as to reduce your need to see a doctor?
4. How confident are you that you can reduce the
emotional distress caused by your high blood pressure
so that it does not affect your everyday life?
5. How confident are you that you can do things other
than just taking medication to reduce how much your
high blood pressure affects your everyday life?

No
Confidence

Slight
Confidence

Moderate
Confidence

High
Confidence

Complete
Confidence

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Note: This self-efficacy scale was adapted from Warren-Findlow, Seymour, and Huber (2012). At the end of visit
two and again at the end of visit three, patients were asked to rate their confidence in managing the variables that
affect their blood pressure management. A five item Likert scale was used with responses ranging from 1- no
confidence to 5- complete confidence.

